Blue Eagle Lithium
High Times
Home > Boards > US OTC > Cannabis >

Cannabics Pharmaceuticals Inc. (CNBX)

Add CNBX Price Alert      Hide Sticky   Hide Intro
Moderator: reconranger
Search This Board: 
Last Post: 10/23/2018 12:17:03 PM - Followers: 165 - Board type: Free - Posts Today: 4


***4/12/2017 NEWS UPDATE*** 

FORBES.COM:  CNBX Added To The U.S. Marijuana Index

***4/7/2017 NEWS UPDATE*** 

Reports Success From Recent Cannabis Study On Cancer


***4/3/2017 NEWS UPDATE*** 

Cannabics Pharmaceuticals Inc. Receives the Final Report of Its
Research on Antitumor Properties of Cannabinoids Held in Israel

Itamar Borochov, CEO of Cannabics Pharmaceuticals said, "The results from this research strengthen our vision of creating anticancer treatments based on natural cannabis medicine".


Bringing Cannabinoid Diagnostics to Personalized Cancer Care

Cannabics Pharmaceuticals Inc. (CNBX), a U.S-based public company, is dedicated to the development of personalized diagnostic tools, aimed to provide supportive data for practitioners and patients regarding cannabinoid based therapy. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company’s focus is on harnessing the therapeutic properties of natural Cannabinoid formulations. Cannabics engages in delivering the maximum amount of supportive data for cancer patients and their doctors, utilizing advanced screening systems and personalized bioinformatics tools.

View entire 24 page presentation :

Cannabics SR' CAPSULES

Long acting oil capsule that provides a safe, effective and reliable administration of cannabis.

Cannabics SR' Capsules, Technology Description - Route of administration
There is a growing number of patients, worldwide, who could benefit from the therapeutic properties of cannabinoids. The unmet need of these patients is a safe, standardized and easy to administer cannabinoid-based therapy. Cannabinoid administration is mainly through smoking, vaporizing, sublingual and oral. While clinical studies show contradictory data regarding a correlation between smoking cannabis and respiratory diseases, most physicians agree that smoking medical cannabis, while having its benefits, is not a healthy nor standardized therapy. 

The pharmacokinetics of THC varies as a function of its route of administration. Pulmonary assimilation of inhaled THC causes a maximum plasma concentration within minutes; psychotropic effects start within seconds to a few minutes, reach a maximum after 15–30 minutes, and taper off within 2–3 hours. Following oral ingestion, psychotropic effects set in with a delay of 30–90 minutes, reach their maximum after 2–3 hours and last for about 4–12 hours, depending on dose and specific effect. Another common route of administration is sublingually. Pure cannabinoids are extracted from the raw plant, dissolved in different oils and administered with a dropper. The beneficial effect of sublingual oil administration is 2-4 hours with a fast onset due to quick absorption through the oral cavity.

The most common oral administration of cannabinoids is through eating edibles, mainly, cookies, chocolate bars and lozenges. Since absorption is attenuated when cannabinoids are ingested orally, Edibles usually contain high dosages of cannabinoids (50-300mg). The high dosage may cause undesirable side effects, mainly, dizziness, anxiety and dissociation. These side effects cause many patients to withdraw from the therapeutic process.  The oral administration route has the longest beneficial effect (4-8 hours) and lacks the undesirable effects of smoking.

Technology currently envisions the licensing of three different formulations: capsules with a 10:1 CBD to THC ratio, a 10:1 THC to CBD ratio and a balanced formulation with 1:1 THC:CBD.

Cannabics Pharmaceuticals Inc. does not manufacture, distribute, dispense or possess any controlled substances, including cannabis or cannabis based preparations. 

Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome...!

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past.

Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."

The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.

The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at :

"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc.

What is A Cannabinoid?

You’ve heard by now that marijuana is a powerful medicinal herb. But, just how powerful is it? The list of medical benefits for these top 10 cannabinoids seems endless.

Security Details Share Structure
  Market Value1 $72,404,107 a/o Jan 13, 2017
Authorized Shares 900,000,000 a/o Dec 30, 2016
Outstanding Shares 107,265,344 a/o Dec 30, 2016
-Restricted 90,368,887 a/o Dec 30, 2016
-Unrestricted 16,896,457 a/o Dec 30, 2016
  Held at DTC Not Available
Float 14,295,638 a/o Jun 30, 2016
  Par Value 0.0001

CNBX Security Details Share Structure
  Market Value1 $37,994,466 a/o Oct 28, 2016
  Authorized Shares 900,000,000 a/o Jul 09, 2015
  Outstanding Shares 107,026,665 a/o Jun 30, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 18,737,071 a/o Jun 30, 2016
  Par Value 0.0001

Blue Eagle Lithium
High Times
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CNBX News: Current Report Filing (8-k) 09/27/2018 06:10:10 AM
CNBX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 09/26/2018 08:06:04 AM
CNBX News: Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) 09/12/2018 09:11:33 AM
CNBX News: Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) 08/21/2018 01:37:30 PM
CNBX News: Current Report Filing (8-k) 08/14/2018 01:02:03 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#3626   But Barhart is %100. Buy,buy,buy. ChuckG1 10/23/18 12:17:03 PM
#3625   It appears the market is not impressed with SBZRUS 10/23/18 10:36:26 AM
#3624   Oh god - I'm -3k at this point Alcatraz99x 10/23/18 10:04:07 AM
#3623   I had thought of tax season but even jim992 10/23/18 01:44:32 AM
#3622   The entire MJ/MMJ sector is taking a huge moxa1 10/22/18 03:45:19 PM
#3621   Jim: It could very well be bigfred1 10/22/18 02:39:18 PM
#3620   New 52-week low! SBZRUS 10/22/18 11:26:10 AM
#3619   CNBX attends 2 conventions a month but never jim992 10/22/18 10:57:49 AM
#3618   Might be a while, although volume is picking ChuckG1 10/22/18 10:28:36 AM
#3617   Thanks jim992, good news,stock is heading for 0.50. ChuckG1 10/22/18 10:23:01 AM
#3616   Hi ChuckG1, There are no stupid jim992 10/22/18 09:30:10 AM
#3615 Pierpont 10/21/18 07:47:13 PM
#3614   This think dropled to $.50 before it skyrocketed H_dog_taco 10/21/18 05:39:26 PM
#3613   Then its not money they need. How can ChuckG1 10/21/18 11:06:12 AM
#3612   They raised 7.5 MM from a very reputable Scuba2 10/21/18 10:12:38 AM
#3611   "Good news/ dropping pps" ChuckG1 10/21/18 08:49:30 AM
#3610   Great news and yet pps drops. jim992 10/21/18 01:55:26 AM
#3609   Thanks for the cheap shares! SBZRUS 10/19/18 11:25:11 PM
#3608   They're spreading the positive results. Only a SBZRUS 10/19/18 01:35:13 PM
#3607 Pierpont 10/19/18 12:43:09 PM
#3606   You people need to just be patient and GoSing 10/19/18 01:18:21 AM
#3605   That would be a good move. SBZRUS 10/18/18 10:59:23 PM
#3604   This needs to uplist to TSX surfgreen 10/18/18 04:59:26 PM
#3603   some one found a bunch of $ mm8s maybe,, ChuckG1 10/18/18 02:40:56 PM
#3602   Ladies and gentleman, i think i see a ChuckG1 10/18/18 01:48:32 PM
#3601   Not bad entry here imo SBZRUS 10/18/18 01:15:26 PM
#3600 Pierpont 10/18/18 01:13:04 PM
#3599   This stock should have ran hard up but Walt123 10/18/18 11:41:12 AM
#3598   Do you have a link that shows the bigfred1 10/18/18 12:23:49 AM
#3597   Might do the same tomorrow. Shorts are covering. SBZRUS 10/17/18 11:06:51 PM
#3596   Doubled down today surfgreen 10/17/18 05:03:44 PM
#3595   I'm buying this news. SBZRUS 10/17/18 04:54:49 PM
#3594   6 month chart looking grim. Alcatraz99x 10/17/18 01:16:47 PM
#3593   Let's see what the rest of the week brings. SBZRUS 10/17/18 10:08:22 AM
#3592   I agree!!! I'm surprised it hasn't affected the freedomdreamer 10/17/18 02:29:05 AM
#3591   Great news today! SBZRUS 10/17/18 12:09:32 AM
#3590   Fantastic results. Let’s get some eyes on this surfgreen 10/16/18 11:00:26 AM
#3589   CNBX Announces Positive Results for Pilot Study on GP65 10/16/18 09:25:35 AM
#3588   Thank you Pierpont!! I love people jim992 10/16/18 02:15:33 AM
#3587   9 millions in royalties is nothing to sneeze bigfred1 10/15/18 10:51:49 PM
#3586   Fairly recent Podcast with the goal to acquire Pierpont 10/15/18 08:02:05 PM
#3585   Thank you for your research. I am weak bigfred1 10/14/18 11:56:52 AM
#3584   Fred, truffleberry 10/13/18 11:33:11 AM
#3583   Will the correction be up or down is GoSing 10/12/18 10:58:54 PM
#3582   50% haircut since positive preclinical results. Major surfgreen 10/12/18 09:05:03 PM
#3581   That is great news for the patients. bigfred1 10/12/18 03:51:15 PM
#3580   NY Times: U.K. to Allow Medical Cannabis Rx GP65 10/12/18 03:03:31 PM
#3579   A company went public at 18 today on bigfred1 10/12/18 01:40:00 AM
#3578   Dr. Gil Bar-Sela is scheduled this coming Monday, GP65 10/11/18 02:12:23 PM
#3577   Let's watch the volume next week AND THE bigfred1 10/10/18 11:00:09 PM